[HTML][HTML] Opportunistic infections in patients receiving daratumumab regimens for multiple myeloma (MM)
Background Daratumumab-based treatment regimens for MM have improved outcomes for
both transplant-eligible and ineligible patients. As a result, patients are receiving longer …
both transplant-eligible and ineligible patients. As a result, patients are receiving longer …
Opportunistic Infections in Patients Receiving Daratumumab Regimens for Multiple Myeloma (MM)
EA Burns, JE Ensor, K Anand, C Gentille, C Guerrero… - Blood, 2021 - ashpublications.org
Background Daratumumab-based treatment regimens for MM have improved outcomes for
both transplant-eligible and ineligible patients. As a result, patients are receiving longer …
both transplant-eligible and ineligible patients. As a result, patients are receiving longer …